493 related articles for article (PubMed ID: 20420170)
21. Hu and Yo antibodies have heterogeneous avidity.
Totland C; Aarseth J; Vedeler C
J Neuroimmunol; 2007 Apr; 185(1-2):162-7. PubMed ID: 17336396
[TBL] [Abstract][Full Text] [Related]
22. Paraneoplastic encephalomyelopathies: pathology and mechanisms.
McKeon A; Pittock SJ
Acta Neuropathol; 2011 Oct; 122(4):381-400. PubMed ID: 21938556
[TBL] [Abstract][Full Text] [Related]
23. Detection of autoantibodies to the BTB-kelch protein KLHL7 in cancer sera.
Bredholt G; Storstein A; Haugen M; Krossnes BK; Husebye E; Knappskog P; Vedeler CA
Scand J Immunol; 2006 Sep; 64(3):325-35. PubMed ID: 16918702
[TBL] [Abstract][Full Text] [Related]
24. Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy.
Sillevis Smitt P; Grefkens J; de Leeuw B; van den Bent M; van Putten W; Hooijkaas H; Vecht C
J Neurol; 2002 Jun; 249(6):745-53. PubMed ID: 12111309
[TBL] [Abstract][Full Text] [Related]
25. [The value of specific neuronal anti-Hu antibody in the early diagnosis of small cell lung cancer].
Wang G; Chen Q; Zhu Y; Ke D; Qian W; Song W
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Dec; 25(12):732-5. PubMed ID: 12622892
[TBL] [Abstract][Full Text] [Related]
26. Imbalance in circulating T lymphocyte subsets contributes to Hu antibody-associated paraneoplastic neurological syndromes.
Zhang L; Qian W; Chen Q; Yin L; Li B; Wang H
Cell Immunol; 2014 Aug; 290(2):245-50. PubMed ID: 25173445
[TBL] [Abstract][Full Text] [Related]
27. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis.
Bernal F; Graus F; Pifarré A; Saiz A; Benyahia B; Ribalta T
Acta Neuropathol; 2002 May; 103(5):509-15. PubMed ID: 11935268
[TBL] [Abstract][Full Text] [Related]
29. New concepts in paraneoplastic neurological syndromes.
Honnorat J; Viaccoz A
Rev Neurol (Paris); 2011 Oct; 167(10):729-36. PubMed ID: 21890156
[TBL] [Abstract][Full Text] [Related]
30. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
31. Paraneoplastic neurological syndromes: a review.
Toothaker TB; Rubin M
Neurologist; 2009 Jan; 15(1):21-33. PubMed ID: 19131854
[TBL] [Abstract][Full Text] [Related]
32. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
Bellone S; Anfossi S; O'Brien TJ; Cannon MJ; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Cancer; 2009 Feb; 115(4):800-11. PubMed ID: 19117353
[TBL] [Abstract][Full Text] [Related]
33. [Paraneoplastic cerebellar degeneration].
Sakai K
Brain Nerve; 2010 Apr; 62(4):357-64. PubMed ID: 20420175
[TBL] [Abstract][Full Text] [Related]
34. SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes.
Tschernatsch M; Gross O; Kneifel N; Kaps M; Blaes F
Autoimmun Rev; 2009 Jun; 8(7):549-51. PubMed ID: 19393214
[TBL] [Abstract][Full Text] [Related]
35. Paraneoplastic neurological syndromes.
Honnorat J; Antoine JC
Orphanet J Rare Dis; 2007 May; 2():22. PubMed ID: 17480225
[TBL] [Abstract][Full Text] [Related]
36. Conflicting consequences of immunity to cancer versus autoimmunity to neurons: insights from paraneoplastic disease.
Steinman L
Eur J Immunol; 2014 Nov; 44(11):3201-5. PubMed ID: 25319369
[TBL] [Abstract][Full Text] [Related]
37. [Paraneoplastic encephalomyelitis/sensory neuropathy].
Tanaka M; Tanaka K
Ryoikibetsu Shokogun Shirizu; 2000; (31):68-72. PubMed ID: 11269191
[No Abstract] [Full Text] [Related]
38. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
39. Paraneoplastic antibodies against HuD detected by a sensitive radiobinding assay.
Storstein A; Monstad SE; Nakkestad HL; Husebye ES; Vedeler CA
J Neurol; 2004 Feb; 251(2):197-203. PubMed ID: 14991355
[TBL] [Abstract][Full Text] [Related]
40. Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Jayaprabhu S; Pecorelli S; Parham GP; Cannon MJ
Clin Cancer Res; 2001 Mar; 7(3 Suppl):804s-810s. PubMed ID: 11300476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]